Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion type Assertion NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_head.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion description "[Here, we show by immunohistochemistry, in patients receiving androgen ablation therapy, that sPLA(2)-IIA remains elevated in remaining cancer cells relative to benign glands after treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_provenance.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion evidence source_evidence_literature NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_provenance.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion SIO_000772 15466184 NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_provenance.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion wasDerivedFrom befree-20150227 NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_provenance.
- NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_assertion wasGeneratedBy ECO_0000203 NP795519.RAITYcFyIa2kJjDX726hC7F2N4aMeu4sAfl6-_PNILc_s130_provenance.